Takeda Pharmaceutical Co Ltd
NYSE:TAK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Takeda Pharmaceutical Co Ltd
NYSE:TAK
|
JP |
|
Tokyo Base Co Ltd
TSE:3415
|
JP |
|
T
|
Textron Inc
F:TXT
|
US |
|
H
|
Hyundai Engineering & Construction Co Ltd
KRX:000725
|
KR |
|
B
|
BYD Co Ltd
XBER:BY6
|
CN |
|
W
|
WeRide Inc
NASDAQ:WRD
|
CN |
Wall St Price Targets
TAK Price Targets Summary
Takeda Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for TAK is 20.02 USD with a low forecast of 16.56 USD and a high forecast of 25.82 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TAK's stock price target?
Price Target
20.02
USD
According to Wall Street analysts, the average 1-year price target for TAK is 20.02 USD with a low forecast of 16.56 USD and a high forecast of 25.82 USD.
What is the Revenue forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
1%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 1%.
What is the Operating Income forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
-5%
Over the last 13 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 2 years is -5%.
What is the Net Income forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
44%
Over the last 13 years, the compound annual growth rate for Net Income has been -1%. The projected CAGR for the next 3 years is 44%.
